When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SNY - AstraZeneca's MEDI8897 nabs accelerated review status in U.S. and Europe
Sanofi
The FDA designates AstraZeneca's (NYSE:AZN) MEDI8897, an extended half-life respiratory syncytial virus (RSV) F monoclonal antibody, a Breakthrough Therapy for the prevention of lower respiratory tract infection caused by RSV.
More news on: AstraZeneca Group plc, Sanofi, Swedish Orphan Biovitrum AB, Healthcare stocks news,